Clinical evaluation and monitoring of lupus kidney disease

Abstract

Lupus renal involvement encompasses a broad range of clinical and histologic presentations and poses numerous therapeutic challenges. Accurate clinical assessment and monitoring requires a comprehensive approach, with attention to the urinalysis, the urinary protein excretion rate, the test of kidney function, and alterations in serologic parameters.

Keywords

glomerular filtration rate kidney function tests lupus nephritis proteinuria

Get full access to this article

View all access options for this article.

References

Domoto DT et al. The significance of electron dense deposits in mild lupus nephritis . Yale Journal of Biology and Medicine 1980; 53: 317–324 .

Golbus J , McCune WJ . Lupus nephritis. Classification, prognosis, immunopathogenesis and treatment . Rheum Dis Clin North Am 1994; 20: 213–242 .

Hebert LA et al. Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus . Am J Kidney Dis 1995; 26: 432–438 .

Wallace DJ et al. Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980 . Am J Med 1982; 72: 209–220 .

Donadio JV Jr , Hart GM , Bergstralh EJ , Holley KE . Prognostic determinants in lupus nephritis: a long term clinicopathologic study . Lupus 1995; 4: 109–115 .

Austin HA , Boumpas DT , Vaughan EM , Balow JE . High-risk features of lupus nephritis: importance of race and clinical and histological factors in 166 patients . Nephrol Dial Transplant 1995; 10: 1620–1628 .

Moroni G et al. ‘Nephritic flares' are predictors of bad long term renal outcome in lupus nephritis . Kidney Int 1996; 50: 2047–2053 .

Fraenkel L et al. Response to treatment as a predictor of longterm outcome in patients with lupus nephritis . J Rheumatol 1994; 21: 2052–2057 .

Rodby RA et al. The urine protein to creatinine ratio as a predictor of 24-hour urine protein excretion in type I diabetic patients with nephropathy: The Collaborative Study Group . Am J Kidney Dis 1995; 26: 904–909 .

10.

Deen WM , Satvat B , Jamieson JM . Theoretical model for glomerular filtration of charged solutes . Am J Physiol 1980; 238: F126–F139 .

11.

Friedman S et al. Glomerular capillary wall function in human lupus nephritis . Am J Physiol 1984; 246: F580–F591 .

12.

Shemesh O , Golbetz H , Kriss JP , Myers DB . Limitations of creatinine as a filtration marker in glomerulopathic patients . Kidney Int 1985; 28: 830–838 .

13.

Bauer JH , Brooks CS , Burch RN . Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate . Am J Kidney Dis 1982; 2: 337–346 .

14.

Zaltzman JS et al. Accurate measurement of impaired glomerular filtration using single-dose oral cimetidine . Am J Kidney Dis 1996; 27: 504–511 .

15.

Roubenoff R et al. Oral cimetidine improves the accuracy and precision of creatinine clearance in lupus nephritis . Ann Intern Med 1990; 113: 501–506 .

16.

Lafayette RA , Perrone RD , Levey AS . Laboratory evaluation of renal function. In: Schrier RW , Gottschalk CW (eds) Diseases of the Kidney. Little, Brown: Boston , 1997, pp 307–354.

17.

Wilson CB , Blantz RC . Nephroimmunopathology and pathophysiology . Am J Physiol 1985; 248: F319–F331 .

18.

Kimberly RP et al. Elevated urinary prostaglandins and the effects of aspirin on renal function in lupus erythematosus . Ann Intern Med 1978; 89: 336–341 .

19.

Kimberly RP , Bowden RE , Keiser HR , Plotz PH . Reduction of renal function by newer nonsteroidal anti-inflammatory drugs . Am J Med 1978; 64: 804–807 .

20.

Klahr S , Schreiner G , Ichikawa I . The progression of renal disease . N Engl J Med 1988; 318: 1657–1666 .

21.

Hill GS , Hinglais N , Tron F , Bach J . Systemic lupus erythematosus: morphologic correlations with immunologic and clinical data at the time of biopsy . Am J Med 1978; 64: 61–79 .

22.

Pillemer SR , Austin HA , Tsokos GC , Balow JE . Lupus nephritis: association between serology and renal biopsy measures . J Rheumatol 1988; 15: 284–288 .

23.

Siegert CEH et al. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus . Ann Rheum Dis 1993; 52: 851–856 .

24.

Coremans IEM et al. Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus . Am J Kidney Dis 1995; 26: 595–601 .

25.

Laitman RS et al. Effect of long-term normalization of serum complement levels on the course of lupus nephritis . Am J Med 1989; 87: 132–138 .

26.

ter Borg EJ et al. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study . Arthritis Rheum 1990; 33: 634–643 .

27.

Bootsma H et al. Prevention of relapses in systemic lupus erythematosus . Lancet 1995; 345: 1595–1599 .

28.

Walz LeBlanc BAE , Gladman DD , Urowitz MB . Serologically active clinically quiescent systemic lupus erythematosus<Eth>predictors of clinical flares . J Rheumatol 1994; 21: 2239–2241 .